The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 03, 2018
Filed:
May. 19, 2016
Applicant:
Amorphex Therapeutics Llc, Reno, NV (US);
Inventors:
Charles D. Leahy, Concord, MA (US);
Edward J. Ellis, Lynnfield, MA (US);
Assignee:
AMORPHEX THERAPEUTICS LLC, Reno, NV (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 47/48 (2006.01); A61K 47/12 (2006.01); A61K 31/46 (2006.01); A61K 31/473 (2006.01); A61K 31/522 (2006.01); A61K 31/7076 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2017.01); G02B 1/04 (2006.01); G02C 7/04 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0051 (2013.01); A61K 31/46 (2013.01); A61K 31/473 (2013.01); A61K 31/522 (2013.01); A61K 31/7076 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01); A61K 47/34 (2013.01); G02B 1/043 (2013.01); G02C 7/04 (2013.01);
Abstract
A non-degradable topical ocular drug delivery device includes about 0.001% to about 10% w/w of at least one myopia-suppressing agent complexed with an immobile acid within a crosslinked polymer matrix. The cross-linked polymer matrix is configured to deliver the least one myopia-suppressing agent over an extended period of time at a concentration and rate that controls myopia progression while preserving pupillary function and accommodation.